BIOCHEMICAL DEBUG - OXIDE_LOOP

I am making provisions for 50hz circuit components to over-seas mail a high-voltage field extraction device for the refinement of cannabis trichome heads which contain a pharmacologically effective treatment for the deficiency of endogenously produced cannabinoids. Cannabinoids are depleted by oxidation which has it's root in the metabolism of dead cancer cells by phagocytic white blood cells which consume and metabolize dead cells to produce oxides which react with cannabinoid molecules. Whether phyto or endogenous, for each there exist scientific confirmation that cannabinoid compounds cause apoptosis (cell death) of cancer cells when biochemically binding with cannabinoid receptors at cancer cell membranes by which the apoptotic chemical signal is communicated to the nucleus of the pathogenic cell which dies. A locally available white blood cell then consumes and metabolizes the dead cancer cell producing the oxide molecules (inflammation) which exo-thermally react with our endogenously produced anti-oxidant cannabinoid compounds.

How do we reach brain or bone marrow chemistry? ..we can choose from at least two cell types by considering the expression of cannabinoid receptors types one or two at the membranes of more than one cell type. Solubility is the chemical property upon which the differentiation of cell and receptor types depends for cannabinoid ligands which biochemically interact with the interior of the cell.

Cells in the brain's biochemistry express cannabinoid type one receptors to chemically bind the hydrophobic molecules (yellow THC, water insoluble). Cells in the bone marrow express cannabinoid type two receptors that bind hydrophilic cannabinoid molecules (red Cannabinol, soluble in water). Application can precede cancer diagnosis by five years. Legal diagnosis of cancer requires biopsies and analyses which confirm the proliferation of cancer cells only after a certain amount of distinguishable proliferation has formed masses which have developed vascular systems that divert resources to the mass of cancer cells.